4,4'-Bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl

Catalog No. :
ACGFYC581
CAS No. :
597570-70-2
Molecular Formula :
C36H20Br4N2
Molecular Weight :
800.19

IUPAC Name:4,4'-bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl

4,4'-Bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-Bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl
IUPAC Name4,4'-bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl
Molecular FormulaC36H20Br4N2
Molecular Weight800.19
SMILESBrC1=CC2=C(N(C3=CC=C(C4=CC=C(N5C6=C(C7=C5C=CC(Br)=C7)C=C(Br)C=C6)C=C4)C=C3)C8=C2C=C(Br)C=C8)C=C1
InChI KeyCLWWYWBDZLUHSR-UHFFFAOYSA-N
Synonym4,4’-bis(4,4’-bis(N-bromocarbazolyl)biphenyl);4,4'-Bis(3,6-dibromo-9H-carbazol-9-yl)biphenyl;4,4'-bis(3,6-dibromo-9H-carbazol-9-yl)-1,1'-biphenyl;9H-Carbazole, 9,9'-[1,1'-biphenyl]-4,4'-diylbis[3,6-dibromo-
CAS No.597570-70-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGFYC581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTBYH032 route compound structure diagram
    ACTBYH0326825-20-3 In Stock
  4. Then
  5. ACGFYC581 route product structure diagram
    ACGFYC581597570-70-2
Inquiry

2. ACGFYC581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVJRN761 route compound structure diagram
    ACVJRN76173087-83-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFYC581 route product structure diagram
    ACGFYC581597570-70-2
Inquiry

Comments (0)